BS
TEVA icon

Boenning & Scattergood’s Teva Pharmaceuticals TEVA Stock Holding History

Boenning & Scattergood’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$94K Hold
10,000
– – 0.02% 392
2022
Q3 		$81K Hold
10,000
– – 0.02% 366
2022
Q2 		$75K Hold
10,000
– – 0.01% 370
2022
Q1 		$94K Hold
10,000
– – 0.02% 392
2021
Q4 		$80K Hold
10,000
– – 0.01% 386
2021
Q3 		$97K Hold
10,000
– – 0.02% 374
2021
Q2 		$99K Hold
10,000
– – 0.02% 370
2021
Q1 		$115K Hold
10,000
– – 0.02% 355
2020
Q4 		$97K Hold
10,000
– – 0.02% 334
2020
Q3 		$90K Sell
10,000
-247
-2% -$2.61K 0.02% 327
2020
Q2 		$126K Buy
10,247
+247
+2% +$2.79K 0.03% 295
2020
Q1 		$90K Buy
+10,000
New +$102K 0.03% 266

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Boenning & Scattergood's TEVA Position: Q4 2022 in Review

Boenning & Scattergood held its Teva Pharmaceuticals (TEVA) position steady in Q4 2022 at 10,000 shares worth $94K. The position accounts for 0.02% of the portfolio, ranked #392.

Boenning & Scattergood first reported a position in TEVA in Q1 2020 and has held it in 12 quarters since. The position peaked at $126K in Q2 2020. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Boenning & Scattergood held 10,000 shares of Teva Pharmaceuticals worth $94K as of Q4 2022.
  • Boenning & Scattergood left its Teva Pharmaceuticals share count unchanged in Q4 2022.
  • Teva Pharmaceuticals made up 0.02% of Boenning & Scattergood's portfolio in Q4 2022, its #392 holding.
  • Boenning & Scattergood first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 12 quarters since.
  • Boenning & Scattergood's Teva Pharmaceuticals position peaked at $126K in Q2 2020.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.